Zobrazeno 1 - 10
of 297
pro vyhledávání: '"Michael J Burke"'
Autor:
Erica Brivio, Edoardo Pennesi, Marieke Willemse, Yilin Jiang, Vincent van der Velden, Berna Beverloo, Chad Hudson, Luke Kuttschreuter, Inge van der Sluis, Benoît Brethon, Francisco Bautista, Michael J. Burke, Nyla Heerema, Andrew Bukowinski, Stacy Cooper, Jessica Pollard, Ramamoorthy Nagasubramani, Michele Redell, Jean-Pierre Bourquin, Ray Pais, Jamie Frediani, Sandeep Batra, Nicoletta Bertorello, Jessica Boklan, Albert Kheradpour, Wade Kyono, Karey Kowalski, Benjamin Mizukawa, Donna Lancaster, Laura Murillo-Sanjuán, Julie Krystal, Yves Bertrand, Alwin Huitema, Harm van Tinteren, Franco Locatelli, Michael Roth, Nobuko Hijiya, Michel Zwaan
Publikováno v:
HemaSphere, Vol 7, p e506783a (2023)
Externí odkaz:
https://doaj.org/article/3cf4638bbdd34168801ad993f868db27
Autor:
Sue Ann Sarpy, Michael J. Burke
Publikováno v:
European Journal of Investigation in Health, Psychology and Education, Vol 11, Iss 4, Pp 1635-1652 (2021)
(1) Background: In this case study, we examined the safety-training-related experiences of individuals from six racial-ethnic groups (Asians (Vietnamese), Blacks, Hispanics, Isleños, Native Americans, and Whites) involved in the cleanup of the Deepw
Externí odkaz:
https://doaj.org/article/468ffc7d502a4cbab5c18e2c127a7090
Autor:
Rachael Schulte, Ashley Hinson, Van Huynh, Erin H. Breese, Joanna Pierro, Seth Rotz, Benjamin A. Mixon, Jennifer L. McNeer, Michael J. Burke, Etan Orgel
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7551-7560 (2021)
Abstract Background Pegaspargase (PEG‐ASP) is an integral component of therapy for acute lymphoblastic leukemia (ALL) but is associated with hepatotoxicity that may delay or limit future therapy. Obese and adolescent and young adult (AYA) patients
Externí odkaz:
https://doaj.org/article/2ae14ad53c6f4dbf96f42808c644d149
Autor:
Lauren Pommert, Robert Burns, Quinlan Furumo, Kirthi Pulakanti, Jon Brandt, Michael J. Burke, Sridhar Rao
Publikováno v:
Cancer Reports, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Background Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in children, representing 25% of all new cancer diagnoses. Advances in genomic sequencing have demonstrated that inherited genetic risk factors play a la
Externí odkaz:
https://doaj.org/article/aaeaa62b52284910bdea6e89b275070d
Autor:
Amy K. Keating, Nathan Gossai, Christine L. Phillips, Kelly Maloney, Kristen Campbell, Andrew Doan, Deepa Bhojwani, Michael J. Burke, Michael R. Verneris
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 1926-1929 (2019)
Externí odkaz:
https://doaj.org/article/4412f34b34974ab999946ef0e2cb7a47
Publikováno v:
The Journal of Physical Chemistry B. 127:2918-2926
Autor:
Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A Heerema, Julie Gastier-Foster, Michael J Borowitz, Brent L Wood, Kelly W Maloney, Leonard A Mattano, Eric C Larsen, Anne L Angiolillo, Michael J Burke, Wanda L Salzer, Stuart S Winter, Patrick A Brown, Erin M Guest, Kimberley P Dunsmore, John A Kairalla, Naomi J Winick, William L Carroll, Elizabeth A Raetz, Stephen P Hunger, Mignon L Loh, Meenakshi Devidas
Publikováno v:
The Lancet Haematology. 10:e129-e141
Publikováno v:
Journal of Pediatrics Review, Vol 5, Iss 2, Pp 19-25 (2017)
Context: Survival after allogeneic hematopoietic stem-cell transplantation (HSCT) for children with hematologic malignancies including acute lymphoblastic leukemia (ALL) continues to improve in part due to advancement in HLA typing and enhanced suppo
Externí odkaz:
https://doaj.org/article/ab19835edd914f9e8ef83b7f76a7b5ef
Autor:
Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas, Yunfeng Dai, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin, Patrick A. Zweidler-McKay, Michael J. Borowitz, Brent Wood, Nyla A. Heerema, Andrew J. Carroll, Naomi Winick, William L. Carroll, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
With modern chemotherapy, approximately 90% of patients with pediatric acute lymphoblastic leukemia are now cured. However, subsets of patients can be identified who remain at very high risk of relapse with expected 4-year disease-free survival rates
Externí odkaz:
https://doaj.org/article/400df5614bb0423c96a66827ab493ef8
Autor:
Kristina K. Hardy, John A. Kairalla, Anthony R. Gioia, Hannah S. Weisman, Meera Gurung, Robert B. Noll, Pamela S. Hinds, Emily Hibbitts, Wanda L. Salzer, Michael J. Burke, Naomi J. Winick, Leanne Embry
Publikováno v:
Pediatric Blood & Cancer. 70